127 related articles for article (PubMed ID: 38910780)
1. Variables Leading to Usage of Alteplase Versus Heparin Lock in Patients With Tunneled Catheters in Hemodialysis Care Project Centers, Saudi Arabia.
Alhammouri J; Ockhuis D; Hibionada E; Albalawi M; Alnahdi R; Hikal B; Koko E; Alano MML; Troncoso M; Hashmi MN
Cureus; 2024 May; 16(5):e60817. PubMed ID: 38910780
[TBL] [Abstract][Full Text] [Related]
2. Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study): study protocol for a randomized controlled trial.
Bruyère R; Soudry-Faure A; Capellier G; Binquet C; Nadji A; Torner S; Blasco G; Yannaraki M; Barbar SD; Quenot JP
Trials; 2014 Nov; 15():449. PubMed ID: 25409678
[TBL] [Abstract][Full Text] [Related]
3. Occluded Tunneled Venous Catheter in Hemodialysis Patients: Risk Factors and Efficacy of Alteplase.
Ponce D; Mendes M; Silva T; Oliveira R
Artif Organs; 2015 Sep; 39(9):741-7. PubMed ID: 25894244
[TBL] [Abstract][Full Text] [Related]
4. Sodium bicarbonate is a potential alternative to classic heparin as a lock solution for non-tunneled dialysis catheters: a result from the prospective randomized BicarbLock trial.
Islam M
Int Urol Nephrol; 2024 Apr; 56(4):1465-1474. PubMed ID: 37823971
[TBL] [Abstract][Full Text] [Related]
5. Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
Winnicki W; Herkner H; Lorenz M; Handisurya A; Kikić Ž; Bielesz B; Schairer B; Reiter T; Eskandary F; Sunder-Plassmann G; Sengoelge G
Kidney Int; 2018 Mar; 93(3):753-760. PubMed ID: 28890326
[TBL] [Abstract][Full Text] [Related]
6. Trisodium citrate 4% versus heparin as a catheter lock for non-tunneled hemodialysis catheters in critically ill patients: a multicenter, randomized clinical trial.
Quenot JP; Helms J; Bourredjem A; Dargent A; Meziani F; Badie J; Blasco G; Piton G; Capellier G; Mezher C; Rebibou JM; Nadji A; Crepin T; Barbar SD; Fleck C; Cransac A; Boulin M; Binquet C; Soudry-Faure A; Bruyère R;
Ann Intensive Care; 2019 Jul; 9(1):75. PubMed ID: 31264073
[TBL] [Abstract][Full Text] [Related]
7. Effective use of alteplase for occluded tunneled venous catheter in hemodialysis patients.
Mendes ML; Castro JH; Silva TN; Barretti P; Ponce D
Artif Organs; 2014 May; 38(5):399-403. PubMed ID: 24117542
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and Cost of Weekly Recombinant Tissue Plasminogen Activator Hemodialysis Catheter Locking Solution.
Hemmelgarn BR; Manns BJ; Soroka SD; Levin A; MacRae J; Tennankore K; Wilson JS; Weaver RG; Ravani P; Quinn RR; Tonelli M; Kiaii M; Mossop P; Scott-Douglas N
Clin J Am Soc Nephrol; 2018 Mar; 13(3):429-435. PubMed ID: 29335321
[TBL] [Abstract][Full Text] [Related]
9. A Randomized Controlled Trial of Comparative Efficacy between Sodium Bicarbonate and Heparin as A Locking Solution for Tunneled Central Venous Catheters Among Patients Requiring Maintenance Hemodialysis.
Wathanavasin W; Phannajit J; Poosoonthornsri M; Lewsuwan S; Tanateerapong P; Chongthanakorn K; Takkavatakarn K; Katavetin P; Tiranathanagul K; Eiam-Ong S; Susantitaphong P
Can J Kidney Health Dis; 2021; 8():20543581211046077. PubMed ID: 34616559
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of taurolidine/urokinase versus taurolidine/heparin as a tunneled catheter lock solution in hemodialysis patients: a prospective, randomized, controlled study.
Al-Ali F; Hamdy AF; Hamad A; Elsayed M; Zafar Iqbal Z; Elsayed A; Ibrahim R; Tolba H; Buanan H; Fawzy A
Nephrol Dial Transplant; 2018 Apr; 33(4):619-626. PubMed ID: 29106676
[TBL] [Abstract][Full Text] [Related]
11. Cefazolin-gentamicin versus taurolidine-citrate for the prevention of infection in tunneled central catheters in hemodialysis patients: A quasi-experimental trial.
Bueloni TNV; Marchi D; Caetano C; de Souza Cavalcante R; Mendes Amaral ML; Ponce D
Int J Infect Dis; 2019 Aug; 85():16-21. PubMed ID: 31102823
[TBL] [Abstract][Full Text] [Related]
12. Tissue plasminogen activator versus heparin for locking dialysis catheters: A systematic review.
Firwana BM; Hasan R; Ferwana M; Varon J; Stern A; Gidwani U
Avicenna J Med; 2011 Oct; 1(2):29-34. PubMed ID: 23210006
[TBL] [Abstract][Full Text] [Related]
13. Locking solutions for hemodialysis catheters; heparin and citrate--a position paper by ASDIN.
Moran JE; Ash SR;
Semin Dial; 2008; 21(5):490-2. PubMed ID: 18764795
[TBL] [Abstract][Full Text] [Related]
14. Low-dose versus high-dose heparin locks for hemodialysis catheters: a systematic review and meta-analysis.
Han X; Yang X; Huang B; Yuan L; Cao Y
Clin Nephrol; 2016 Jul; 86(7):1-8. PubMed ID: 27191662
[TBL] [Abstract][Full Text] [Related]
15. Alteplase vs. urokinase for occluded hemodialysis catheter: A randomized trial.
Pollo V; Dionízio D; Bucuvic EM; Castro JH; Ponce D
Hemodial Int; 2016 Jul; 20(3):378-84. PubMed ID: 26851872
[TBL] [Abstract][Full Text] [Related]
16. Tunneled Hemodialysis Catheter Tip Design and Risk of Catheter Dysfunction: An Australian Nationwide Cohort Study.
Lazarus B; Polkinghorne KR; Gallagher M; Coggan S; Gray NA; Talaulikar G; Kotwal S;
Am J Kidney Dis; 2024 Apr; 83(4):445-455. PubMed ID: 38061534
[TBL] [Abstract][Full Text] [Related]
17. Does the heparin lock concentration affect hemodialysis catheter patency?
Ivan DM; Smith T; Allon M
Clin J Am Soc Nephrol; 2010 Aug; 5(8):1458-62. PubMed ID: 20498241
[TBL] [Abstract][Full Text] [Related]
18. Tissue plasminogen activator vs heparin for locking central venous catheters between apheresis procedures.
Mathur G; Mott SL; Collins L; Schlueter AJ
J Clin Apher; 2019 Aug; 34(4):445-449. PubMed ID: 30829414
[TBL] [Abstract][Full Text] [Related]
19. Systematic review of locking solutions for non-tunneled hemodialysis catheters.
Boucley I; Dargent A; Andreu P; Roudaut JB; Aptel F; Labruyère M; Jacquier M; Cransac A; Quenot JP
Hemodial Int; 2023 Jan; 27(1):12-20. PubMed ID: 36203330
[TBL] [Abstract][Full Text] [Related]
20. Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
Zhao Y; Li Z; Zhang L; Yang J; Yang Y; Tang Y; Fu P
Am J Kidney Dis; 2014 Mar; 63(3):479-90. PubMed ID: 24125729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
